We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Kenneth Remy, MD

Kenneth Remy, MD

  • Primary Location: 11100 Euclid Ave (0 mi.)
    Other Locations
  • Languages Spoken: English

Office Locations

UH Cleveland Medical Center Bolwell (0 mi.)

11100 Euclid Ave
Bolwell 6th Floor
Cleveland, OH 44106
216-844-8500

Biography: Kenneth Remy, MD

Expertise

  • Critical Care
  • Pediatric Critical Care
  • Sleep Medicine

Titles

  • Co-Director, Pediatric Critical Care Clinical, Basic and Translational Research Program, UH Rainbow Babies and Children's Hospital
  • Director, Blood, Heart, Lung and Immunology Research Center, UH Cleveland Medical Center
  • Director, Basic Science and Translational Adult Critical Care Research, UH Cleveland Medical Center
  • Associate Professor of Medicine, CWRU School of Medicine

Certifications & Memberships

  • Pediatric Critical Care Medicine - American Board of Pediatrics
  • Critical Care Medicine - American Board of Internal Medicine
  • Pediatrics - American Board of Pediatrics
  • Internal Medicine - American Board of Internal Medicine

Education

Other Education
Duke University School Of Medicine (2012 - 2015)

Fellowship | Critical Care Medicine
Critical Care Medicine - National Institutes Of Health (2011 - 2015)

Fellowship | Pediatric Critical Care Medicine
Pediatric Critical Care Medicine - New York-Presbyterian/Columbia University Medical Center (2008 - 2011)

Residency | Internal Medicine/Pediatrics
Internal Medicine/Pediatrics - UH Case Medical Center (2004 - 2008)

Other Education
Washington University In St Louis (2020)

Medical Education
Jefferson Medical College Of Thomas Jefferson University (2004)

Undergraduate
University Of Delaware (1999)

About

Dr. Remy is a tenure track Associate Professor and NIH funded physician-scientist in the Departments of Internal Medicine, Pediatrics, Pathology, and Biochemistry in the Divisions of Pulmonary Critical Care Medicine and Pediatric Critical Care Medicine. He serves as the Director of the Division of Pulmonary Critical Care Medicine Basic Science and Translational Critical Care Research and Co-Director for Clinical, Basic Science, and Translational Critical Care Research in the Division of Pediatric Critical Care Medicine. Previously, Dr. Remy was an Associate Professor at Washington University in St. Louis in the Departments of Pediatrics and Internal Medicine. At Washington University, Dr. Remy successfully completed the Academic Medical Leadership Program for Physicians and Scientists in the School of Medicine, the Olin Business School and BJC HealthCare.

Dr. Remy is an international expert in adult and pediatric sepsis, COVID disease, and global health. As an adult and pediatric critical care physician, his laboratory is focused on two areas: heme-based trafficking and signaling in immune dysregulation in context of diseases of intravascular hemolysis (COVID, sepsis, malaria, sickle cell disease, thalassemia) and after red blood cell transfusion; and real time immunophenotyping of pro and hypoinflammatory states to identify timing for immunoadjuvant therapies. During the COVID-19 pandemic, Dr. Remy has cared for over two thousand patients in the adult and pediatric ICU while pivoting his laboratory activities to understanding the evolution of the disease in both a hematologic and immune functional approach. Dr. Remy in collaboration with Dr. Richard Hotchkiss were among the first in world to demonstrate a covid-19 immunosuppressive phenotype demonstrating significant T cell exhaustion in patients with critical illness. Dr. Remy’s first authored manuscript on care of adults in the pediatric ICU was the featured article in Pediatric Critical Care Medicine. He has been featured on a number of news programs including CNN, CBS Evening News, BBC News, People Magazine, NBC News, Reuters, USA today, and many other local and international news stations on his experiences during this pandemic and speaking on the immunologic consequences of disease, pediatric multisystem inflammatory syndrome (MIS-C), public health measures and schools, and potential therapies for SARS-CoV-2 infection. Dr. Remy sits on a number of national and international task forces in sepsis and COVID including the NIH, BARDA, FDA, CDC, and many others. Dr. Remy has authored over 75 peer reviewed manuscripts, textbook chapters, and invited commentaries. He is the chair of the basic and translational science research section for the society of critical care medicine (SCCM); the largest society for critical care practitioners in the world with over 25,000 members. Additionally, he is the immunology chair for the pediatric acute lung injury and sepsis investigators blood network, and holds key leadership positions in many other organizations including executive committee of the research section of SCCM and member at large for the Internal Medicine section of SCCM. He has been honored as a fellow in the American College of Critical Care Medicine and fellow in the society of Pediatric Research. Prior to Case Western University, University Hospitals of Cleveland, and Washington University: Dr. Remy holds a Medical Degree from Jefferson Medical College and Masters’ Degrees from Duke University (Clinical Research) and Washington University in St. Louis (Translational Research; immunology focus). He completed dual residencies in Internal Medicine and Pediatrics at Case Western University/University Hospitals of Cleveland/Rainbow Babies and Children’s Hospital in Cleveland, Ohio, Pediatric Critical Care fellowship at New York Presbyterian Hospital-Columbia University in New York City, and Adult Critical Care Fellowship at the National Institutes of Health in Bethesda, MD. He is quadruple boarded in each of these specialties.

Additionally, he is formally trained in Global Health and emergency and disaster preparedness; and has received a certificate of clinical research from the National Institutes of Health. He is also the medical director (ICU captain) for Heart Care International’s Medical Missions and global health chair for the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. He Co-founded the first-in-world Global Health Critical Care Fellowship in Blantyre Malawi in 2017 and remains a co-fellowship director.

Dr. Remy’s has clinical interests in both adults and children in bioethics, international health, humor therapy, and palliative care. Previous research has been in calcium activated chloride channels in airway smooth muscle and in therapeutics to bacillus anthracis induced shock. His research interests are in host inflammatory response in sepsis.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Kenneth Remy did not disclose any Outside Relationships with Industry.